170842 ⎘
Detection or diagnosis of diseases; Neurological disorders; Dementia; Cognitive disorders Alzheimer
AGENTS FOR SUPPRESSING NEURAL FIBROTIC DEGENERATION
#1202GENETIC POLYMORPHISMS ASSOCIATED WITH ALZHEIMER'S DISEASE, METHODS OF DETECTION AND USES THEREOF
#1203Identification of Compounds Suitable for Treating Ad
#1204Methods for detecting the presence of mutant mammalian presenilin protein
#1205Anti-Aβ globulomer 5F7 antibodies
#1206Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease
#1207Use of the ornithine transcarbamylase (), as a marker for diagnosing brain damages
#1208Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases
#1209CONFORMATIONAL ISOMERS OF ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS OF THEIR MANUFACTURE AND USE
#1210Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
#1211Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease
#1212DETECTING SOLUBLE A-BETA
#1213Low-Density Lipoprotein Receptor-Related Protein 2 Clears Amyloid-Beta Peptide A cross the Blood-Brain Barrier via Apolipoprotein J
#1214HUMANIZED ANTIBODY IGG1
#1215Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#1216Isolated microtubule-associated protein tau peptides and kit
#1217Methods for identifying substances for the treatment of Alzheimer's disease
#1218Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
#1219Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases
#1220Biomarkers for neurodegenerative disorders
#1221Methods of screening for compounds that inhibit binding between amyloid-β(Aβ) and FC-γ receptor IIB (FcγRIIb)
#1222Antibody having inhibitory effect on amyloid fibril formation
#1223Ascorbic acid conjugates
#1224Method for diagnosing alzheimer's disease
#1225LXR ligand testing method
#1226Amyloid [β] Beta fibrillogenesis-inhibiting peptide
#1227Assay method for identifying drug candidate
#1228INFECTIVITY ASSAY
#1229Alzheimer's related proteins and methods of use
#1230Multiplexed biomarkers for monitoring the Alzheimer's disease state of a subject
#1231Method for identifying modulators of NOAH10 useful for treating Alzheimer's disease
#1232Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities
#1233Apolipoprotein E3 protein as a biomarker of Parkinson's disease
#1234Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer's Disease
#1235Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases
#1236HIGH SENSITIVITY IMMUNOASSAYS AND KITS FOR THE DETERMINATION OF PEPTIDES AND PROTEINS OF BIOLOGICAL INTEREST
#1237Aβ conformer selective anti-aβ globulomer monoclonal antibodies
#1238Truncated Fragments of Alpha-Synuclein in Lewy Body Disease
#1239Alzheimer's Disease-Specific Alterations of the Erk1/Erk2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)
#1240Lipid profile as a biomarker for early detection of neurological disorders
#1241Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
#1242Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
#1243Methods of diagnosing or prognosing Alzheimer's disease
#1244Alzheimer's Disease Examination Method
#1245Monoclonal antibody
#1246Monoclonal antibody
#1247Methods compositions and compound assays for inhibiting amyloid-beta protein production
#1248Method for preventing and treating Alzheimer's disease
#1249Novel Integrin Ligand ITGL-TSP
#1250Method for Diagnosing Neuro-Degenerative Disease
#1251METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF ALZHEIMER'S DISEASE
#1252METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF ALZHEIMER'S DISEASE
#1253Screening G protein-coupled receptor antagonists for methods of treating Alzheimer's disease
#1254Compositions Comprising Addl Receptors, Related Compositions, and Related Methods
#1255AGENTS FOR PROPHYLAXIS OR TREATMENT OF NEUROLOGICAL RELATED DISEASES AND CONDITIONS
#1256Diagnostic and Therapeutic use of a Plasma Membrane Atpase
#1257Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
#1258GENES ASSOCIATED WITH ALZHEIMER'S DISEASE - Hltdip
#1259Antibody specific for mutant presenilin 2 and method of use thereof
#1260Diagnostic and Therapeutic Use of the Kcne4 Gene and Protein for Alzheimer's Disease
#1261Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
#1262Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative Patients
#1263AGENTS THAT REDUCE NEURONAL OVEREXCITATION
#1264Prevention and treatment of amyloidogenic diseases
#1265Prevention and treatment of amyloidogenic diseases
#1266Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity
#1267Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
#1268Combination of Rosiglitazone and Donepezil for Improvement of Cognitive Function
#1269Alzheimer's disease-specific alterations of the ERK1/ERK2 Phosphorylation ratio-Alzheimer's disease-specific molecular biomarkers (ADSMB)
#1270Biomarkers and assays for Alzheimer's disease
#1271Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases
#1272Inhibition of tau-tau association
#1273DIAGNOSTIC MARKER FOR NEURODEGENERATIVE DISEASES
#1274Csf Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases
#1275Method for the Diagnosis of Alzeimer's Disease
#1276In vitro method for the diagnosis of neurodegenerative diseases
#1277Method of Assaying Alzheimer's Disease and Diagnostic Reagent
#1278Methods and compositions for treating neurological disorders
#1279Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same
#1280Anti-addl antibodies and uses thereof
#1281Microglia Facilitated Amyloidogenesis Assay
#1282Genes Involved in Neurodegenerative Conditions
#1283Neurodegenerative Markers for Psychiatric Conditions
#1284ASSAYS FOR DETECTING NATIVE-STATE PROTEINS AND IDENTIFYING COMPOUNDS THAT MODULATE THE STABILITY OF NATIVE-STATE PROTEINS
#1285Markers for brain damage
#1286Human anti-amyloid β peptide antibody and fragment of said antibody
#1287Methods and Compositions for the Detection of Protein Folding Disorders
#1288Measurement of GGA proteins for diagnosing BACE associated disease
#1289Method for detecting candidate alzheimer's disease drug
#1290Biomarkers of Alzheimer's Disease
#1291Methods of diagnosing Alzheimer's disease
#1292Method for Differentiation of Alzheimer's Disease into Subgroups
#1293ALZHEIMER'S DISEASE THERAPEUTICS BASED ON PIN-1 CATALYZED CONFORMATIONAL CHANGES IN PHOSPHORYLATED AMYLOID PRECURSOR PROTEIN
#1294Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
#1295Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
#1296Neuroactive fragments of APP
#1297COMPOSITIONS AND METHODS FOR DETECTING AND QUANTIFYING TOXIC SUBSTANCES IN DISEASE STATES
#1298Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's Disease
#1299Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a
#1300Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene
#1301Biomarkers of mild cognitive impairment and alzheimer's disease
#1302Monoclonal antibodies and use thereof
#1303Remedy for Alzheimer's Disease
#1304Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#1305IRON REGULATING PROTEIN-2 (IRP-2) AS A DIAGNOSTIC FOR NEURODEGENERATIVE DISEASE
#1306ADDL Binding to Hippocampal Neurons
#1307Predicting Alzheimer's Disease
#1308APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER
#1309Assays and methods to detect beta-secretase and its activity in body fluids and tissue extracts
#1310HUMAN CDNAS AND PROTEINS AND USES THEREOF
#1311Modulator of gamma-secretase
#1312Diagnostic Method for Alzheimier's Disease
#1313Methods And Compositions Comprising Non-Peptide Small Molecules That Solubilize Beta Amyloid Peptide Fiber
#1314Treatment Of Neurodegenerative Diseases By The Use Of Atp7a
#1315T1 Receptor-Like Ligand II and Uses Thereof
#1316Diagnostic and Therapeutic Use of the Human Dax-1 Gene and Protein for Neurodegenerative Diseases
#1317Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator
#1318Abeta42 LOWERING AGENTS
#1319Abeta42 LOWERING AGENTS
#1320Modulators of beta-amyloid peptide aggregation comprising D-amino acids
#1321Neuroprotection with Beta-Lactam Compounds
#1322Amyloid beta protein channel structure and uses thereof in identifying potential drug molecules for neurodegenerative diseases
#1323Methods and compounds for detection of medical disorders
#1324Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)
#1325Quick Test for the Diagnosis of Alzheimer's Disease
#1326Screening method for the identification of a drug for the development of an agent for prevention and/or treatment of Alzheimer's disease
#1327Method for Detecting Alzheimer's Disease and other Forms of Dementia, and Measuring Their Progression
#1328Diagnostic and therapeutic use of F-box proteins for Alzheimer's disease and related neurodegenerative disorders
#1329Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
#1330Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#1331Inhibition of tau-tau-association
#1332Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases
#1333Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#1334Protein isoforms and uses thereof
#1335Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
#1336Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
#1337Inhibitor for the formation of y-secretase complex
#1338Non-immunostimulatory antibody and compositions containing the same
#1339Neuroprotective activity of activated protein c independent of its anticoagulant activity
#1340Modulation of synaptic maintenance
#1341METHOD OF DIAGNOSING ALZHEIMER'S DISEASE BY DETECTION OF CHLAMYDIA PNEUMONIAE
#1342Method for diagnosis of alzheimer's disease
#1343PHARMACEUTICAL COMPOSITIONS FOR SUPPRESSING B-AMYLOID PRODUCTION
#1344Marker peptide for alzheimer's disease
#1345Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
#1346Sirt1 and genetic disorders
#1347antibodies binding to a C-terminal fragment of apoliopoprotein E
#1348Biomarkers for neurodegenerative disorders
#1349Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
#1350Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratio
#1351Anti-ADDL monoclonal antibody and use thereof
#1352Oxidative stress measurement device and related methods
#1353Soluble low-density lipoprotein receptor related protein binds directly to Alzheimer's amyloid-beta peptide
#1354Methods for binding agents to b-amyloid plaques
#1355Anti-ADDL antibodies and uses thereof
#1356Treatment of Alzheimer's Disease
#1357Assay for differentiating Alzheimer's and Alzheimer's-like disorders
#1358Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#1359Methods and compositions for diagnosis, stratification, and monitoring of Alzheimer's disease and other neurological disorders in body fluids
#1360Methods for modulating transcriptional activation using mint proteins
#1361Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
#1362Novel Integrin Ligand ITGL-TSP
#1363Means for detecting pathological transformation of the APP protein and their uses
#1364Novel Integrin Ligand ITGL-TSP
#1365Methods of detecting a fragment of neurosecretory protein VGF for diagnosing alzheimer's disease
#1366Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
#1367Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases
#1368Compositions and methods for treatment of chronic and infectious diseases
#1369Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#1370Vaccine compositions for prevention of chronic and infectious diseases
#1371Diagnosis and treatment of Alzheimer disease
#1372METHOD FOR REDUCING LYSOZYME ENZYMATIC ACTIVITY
#1373In situ click chemistry method for screening high affinity molecular imaging probes
#1374Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases
#1375Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases
#1376Truncated fragments of alpha-synuclein in Lewy body disease
#1377Agglomeration protein cascades, compositions and methods regarding the same
#1378Cryopreservation media and molecules
#1379Receptor
#1380Therapeutic agent for Abeta related disorders
#1381Biomarkers for diagnosing alzheimer's disease
#1382Immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
#1383Method of monitoring immunotherapy
#1384Anti-ADDL antibodies and uses thereof
#1385Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases
#1386Human cDNAs and proteins and uses thereof
#1387Prevention and treatment of amyloid-associated disorders
#1388Method to diagnose and evaluate progression of Alzheimer's disease
#1389Fibronectin precursor biopolymer markers indicative of alzheimer's disease
#1390Method for measuring the level of anti-beta-amyloid antibody in body fluids and diagnostic kit for alzheimer's disease using same
#1391Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#1392Alzheimer's related proteins and methods of use
#1393Protein and its use in diagnosing Alzheimer's disease
#1394Atypical protein kinase C isoforms in disorders of the nervous system and cancer
#1395Methods of identification of biomarkers with mass spectrometry techniques
#1396Truncated tau proteins
#1397Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseases
#1398IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
#1399Signaling intermediates in an in vitro model of Alzheimer's disease
#1400Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof
#1401Method of detecting or diagnosing of a neurodegenerative disease or condition
#1402Assays for fprl-1 ligands
#1403Prediction of Parkinson's disease using gene expression levels of peripheral blood samples
#1404Method for retarding or precluding Alzheimer's dementia
#1405N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions
#14062'-5'-oligoadenylate synthetase like protein as a biomarker for neurodegenerative disease
#1407FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease
#1408Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease
#1409Transgenic animal expressing alzheimer's tau protein
#1410Methods for the identification of compounds for the treatment of Alzheimer's disease
#1411System and method for providing personalized healthcare for alzheimer's disease
#1412Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
#1413Diagnostic and therapeutic use of a voltage-gated ion channel scn2a for neurodegenerative diseases
#1414CaMKII/calcium channel binding-related compositions and methods
#1415Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases
#1416Compositions and methods for detecting pathogen infection
#1417Diagnosis of Alzheimer's disease
#1418Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases
#1419Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases
#1420Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity
#1421Gamma secretase substrates and in vitro assays
#1422Methods and compositions for treating Alzheimer's disease
#1423Methods for decreasing beta amyloid protein
#1424Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
#1425Protein biopolymer markers predictive of alzheimer's disease
#1426Human brain carboxypeptidase B antibodies
#1427Complex of a chaperone with β-amyloid and methods employing this complex
#1428Immunoglobulin-positive neurons in Alzheimer disease are dying via the classical, antibody-dependent, complement pathway
#1429Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseases
#1430GPR54 knock-out mammals and screening methods using them
#1431Modulators of β-amyloid peptide aggregation comprising D-amino acids
#1432Inhibition of tau-tau-association
#1433Method for differentiation of Alzheimer's Disease into subgroups
#1434Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same
#1435Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#1436Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#1437Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#1438Evaluation of a treatment to decrease the risk of a progressive brain disorder or to slow brain aging
#1439Compositions and kits for detecting pathogen infection
#1440Purified antigen for Alzheimer's disease and methods of obtaining and using same
#1441Method of detecting and preventing Alzheimer's disease, particularly at prodromal and early stages
#1442Methods for diagnosing and treating Alzheimers disease and Parkinson's disease
#1443Methods for identifying a compound that inhibits the procession of amyloid-beta protein production in a mammalian cell expressing APP and overexpressing a G-protein coupled receptor in the cell
#1444Reagent for detecting risk factor of alzheimer's disease, detection kit therefor and method of detecting risk factor of alzheimer's disease using the same
#1445Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease
#1446Prevention and treatment of amyloidogenic disease
#1447Methods and systems for detection and monitoring of neurodegenerative diseases using magnetic resonance spectroscopy
#1448Biomarkers for alzheimer's disease
#1449Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
#1450Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664
#1451Low-density lipoprotein receptor related protein-1 (LRP-1)in clearance of alzheimer's amyloid-beta peptide from the central nervous system
#1452Reagents and methods for identification of binding agents
#1453Methods for diagnosis of Alzheimer's Disease in blood samples
#1454Method of treating amyloid beta precursor disorders
#1455Antibody specific for mutant presenilin 1
#1456Diagnostic and therapeutic use of an activator protein for vesicle secretion for neurodegenerative diseases
#1457Novel integrin ligand ITGL-TSP
#1458Compounds for the diagnosis/prevention/treatment of alzheimer's disease
#1459Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
#1460Methods and compositions comprising non-peptide small molecules that solubilize the alzheimer's Abeta peptide fiber
#1461Abeta42 lowering agents
#1462Antibody specific to central nervous system tau protein
#1463Soluble complex comprising a retroviral surface glycoprotein
#1464Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
#1465Methods and compositions relating to modulating amyloid precursor protein cleavage
#1466Treatment of vascular dysfunction and alzheimer's disease
#1467Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
#1468Methods for modulating macrophage proliferation using polyamine analogs
#1469Amyloid beta is a ligand for FPR class receptors
#1470Methods of diagnosing or treating Alzheimer's disease on basis of increased cerebrospinal fluid levels of nerve growth factor
#1471Polymorphism of soati useful for identifying risk of developing alzheimer's disease
#1472Antibodies specific for toxic amyloid beta protein oligomers
#1473Regulated nucleic acids in pathogenesis of alzheimer's disease
#1474Amyloid beta-peptide and methods of use
#1475Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
#1476Method of screening for drugs useful in treating Alzheimer's disease
#1477Diagnostic and therapeutic use of ma onconeuronal antigents for neurodegenerative diseases
#1478Aβlowering agents
#1479Rapid method of determining clearance of prion protein
#1480Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
#1481Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau
#1482Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
#1483Discordant helix stabilization for prevention of amyloid formation
#1484Prevention and treatment of amyloidogenic disease
#1485Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof
#1486Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determining cyp46 genotype
#1487Compositions and methods for diagnosing Alzheimer's disease
#1488β-Secretase variant
#1489Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation
#1490Methods for diagnosing dementia-related neurological disorders
#1491Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
#1492Transgenic mice expressing inducible human p25
#1493Color-changing eye drops for early screening alzheimer's disease and application thereof
#1494Molecular diagnostic kits for evaluating stress